13F

Stock

BridgeBio Pharma, Inc.

BBIO · held by 5 managers

Reported value

$40.8M

Holders

5

+2 new · −0 exited

Holders’ est. mark

$3.35M

Price effect on 2 books still in the name

Largest holder

$40.3M

BARCLAYS PLC

Holder count by quarter

Who holds it

Notable only
InvestorSharesValueEst. markChange
BARCLAYS PLC933.5K$40.3M$3.35MAdded$26.9M
Henshaw Capital LLC8.26K$356.5KNew
DANSKE BANK A/S2K$86.4KNew
Essential Partners LLC305$13.2KHeld
Leonteq Securities AG284$12.3K$2.35KCut−$10.6K

Positions as of Q2 2025. 13F filings arrive up to 45 days after quarter-end and omit shorts. Values are quarter-end marks, as filed. Estimated mark is the price effect on shares still held — not realized P&L or investment advice.